🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Content Elimination

According to TikTok, the platform has taken down violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the service secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, positive testimonials and step-by-step instructions for preparing or administering at residence.

Within moments of entering one community, a vendor posted contact information, where most purchases occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Details and Costs

Inside these communities, posts show dark colored packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially serious health risks”.